Pulmonary Exacerbation Treatment Response in Cystic FibrosisPulmonary Exacerbation Treatment Response in Cystic Fibrosis
This article looks at both the short- and long-term therapeutic success -- and failure -- of treatments for pulmonary exacerbation in cystic fibrosis. Thorax (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 6, 2016 Category: Consumer Health News Tags: Pulmonary Medicine Journal Article Source Type: news

4 Advances That Make In Vitro Fertilization More Successful Than Ever
Tanmoy Mukherjee, MD Associate Director, Division of Reproductive Endocrinology and Infertility, Mount Sinai Health System; Co-Director, Reproductive Medicine Associates of New York; Assistant Clinical Professor of Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai When prospective parents who are unable to conceive a child on their own consult me for assistance, I am excited to help them build their families. But for them, dealing with the challenges of infertility can be as stressful as having cancer. Fortunately, the latest advances in in vitro fertilization (IVF) are giving them a ...
Source: Healthy Living - The Huffington Post - April 4, 2016 Category: Consumer Health News Source Type: news

Liver brothers: Two lives linked by split-liver transplant
It is late in the evening on June 14, 2015. Kern Tyler and his wife Pasina Mazoka-Tyler sit in a waiting room at Boston Children’s Hospital, while their 11-month-old son Malambo Mazoka-Tyler, born with a life-threatening disease called biliary atresia, undergoes a liver transplant. To arrive at this moment, they have traveled vast distances, visited multiple hospitals, sought the advice and counsel of numerous doctors, packed all their belongings and moved more than 7000 miles from their home in Zambia, Africa, to Boston, Massachusetts. He had picked out what he wanted to wear, where he wanted to be buried, and ...
Source: Thrive, Children's Hospital Boston - April 4, 2016 Category: Pediatrics Authors: Emily Williams Tags: Our Patients’ Stories biliary atresia cystic fibrosis Cystic Fibrosis Center end-stage liver disease Heung Bae Kim Khashayar Vakili liver failure Liver transplant Liver Transplant Program Rima Fawaz Split liver transplantation Source Type: news

Liver brothers: Two lives linked by split-liver transplant
It is late in the evening on June 14, 2015. Kern Tyler and his wife Pasina Mazoka-Tyler sit in a waiting room at Boston Children’s Hospital, while their 11-month-old son Malambo Mazoka-Tyler, born with a life-threatening disease called biliary atresia, undergoes a liver transplant. To arrive at this moment, they have traveled vast distances, visited multiple hospitals, sought the advice and counsel of numerous doctors, packed all their belongings and moved more than 7000 miles from their home in Zambia, Africa, to Boston, Massachusetts. He had picked out what he wanted to wear, where he wanted to be buried, and ...
Source: Thrive, Children's Hospital Boston - April 4, 2016 Category: Pediatrics Authors: Emily Williams Tags: Our Patients’ Stories biliary atresia cystic fibrosis Cystic Fibrosis Center end-stage liver disease Heung Bae Kim Khashayar Vakili liver failure Liver transplant Liver Transplant Program Rima Fawaz Split liver transplantation Source Type: news

Microsoft's Xbox Kinect Breathes New Life into Respiratory Assessment
Xbox Kinects could be used in the future to assess the health of patients with conditions such as cystic fibrosis. Researchers at the Institute of Digital Healthcare, WMG, University of Warwick and the Institute of Inflammation and Ageing, University of Birmingham and Heart of England NHS Foundation Trust (HEFT) have developed a method of using the devices. (Source: eHealth News EU)
Source: eHealth News EU - April 4, 2016 Category: Information Technology Tags: Featured Research Research and Development Source Type: news

What is the Recurrence Risk for Clostridium difficile Infection?
Discussion Clostridium difficile infection (CDI) is a common cause of nosocomial diarrhea. Clostridium difficile is an obligate, anaerobic, gram-positive bacillus that is spore-forming and toxin producing. It is resistant to acid, heat, antibiotics and many antiseptic agents. Spores are acquired from the environment or by oral-fecal route. Once in the colon, the bacteria attach and proliferate making vegetative forms. Two main toxins are produced which disrupt the colonic integrity. Toxin A (TcdA) is an endotoxin that disrupts the mucosal cells. Toxin B (TcdB) is a cytotoxin that is 1000x more potent than TcdA and causes a...
Source: PediatricEducation.org - March 28, 2016 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Microsoft's Xbox Kinect Breathes New Life Into Respiratory Assessment
Xbox Kinects could be used in the future to assess the health of patients with conditions such as cystic fibrosis. (Source: Medical Design Online News)
Source: Medical Design Online News - March 24, 2016 Category: Medical Equipment Source Type: news

HOW TO DO MANUAL CHEST PT (Airway Clearance)
<!--cke_bookmark_218S--><!--cke_bookmark_218E--> Here's how we do Manual Chest PT (Physical Therapy or Physiotherapy) for airway clearance. Cystic Fibrosis causes an excessive amount of thick, infected mucus in the lungs that requires routine percussion & drainage therapy... so here's a few tips & tricks we've picked up over the years! (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - March 23, 2016 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Xbox Kinect Tech Harnessed To Monitor Cystic Fibrosis, Other Lung Diseases
Researchers in the United Kingdom have rigged a gaming console to help assess patients with cystic fibrosis and other respiratory conditions. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 23, 2016 Category: Pharmaceuticals Authors: Emily Mullin Source Type: news

Microsoft's Xbox Kinect breathes new life into respiratory assessment
(University of Warwick) Xbox Kinects could be used in the future to assess the health of patients with conditions such as cystic fibrosis.Normally found in the hands of gamers rather than medics the Microsoft sensors could be used to assess the respiratory function of patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 22, 2016 Category: Global & Universal Source Type: news

Complex Care Center Forges New Outpatient Model
UR Medicine's Complex Care Center is Rochester’s first primary care practice dedicated to caring for adults with chronic childhood-onset conditions such as cystic fibrosis, sickle cell anemia, childhood cancers, autism, and intellectual and developmental disabilities. (Source: University of Rochester Medical Center Press Releases)
Source: University of Rochester Medical Center Press Releases - March 17, 2016 Category: Universities & Medical Training Source Type: news

​Eight new things keeping Vertex Pharmaceuticals up at night in 2016
New competitors. Comments by presidential candidates. Recent collaborations. Potential changes to corporate tax laws. Those are some of the new things top executives at Vertex Pharmaceuticals (Nasdaq: VRTX) revealed as potential “risk factors” in the company’s most recent annual report. The 1,950-employee company saw considerable changes over the past year with the launch of Orkambi, its new cystic fibrosis drug, which is expected to take over as the firm’s biggest moneymaker in the next… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 8, 2016 Category: Biotechnology Authors: Don Seiffert Source Type: news

Evolving insights into cystic fibrosis lung infections
Recent research progress into how bacteria adapt and evolve during chronic lung infections in cystic fibrosis patients could lead to better treatment strategies being developed, according to a new study. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 4, 2016 Category: Science Source Type: news

Evolving insights into cystic fibrosis lung infections
(University of Liverpool) Recent research progress into how bacteria adapt and evolve during chronic lung infections in cystic fibrosis patients could lead to better treatment strategies being developed, according to a new review by the University of Liverpool. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 4, 2016 Category: Infectious Diseases Source Type: news

Savara Pharmaceuticals Completes $20 Million Round of Financing
Preparation underway for Phase 3 trial of AeroVanc for MRSA lung infection in people with cystic fibrosis AUSTIN, Texas, March 1, 2016 -- (Healthcare Sales & Marketing Network) -- Savara Pharmaceuticals announced today that it has closed a $20 million ... Biopharmaceuticals, Venture CapitalSavara Pharmaceuticals, AeroVanc, cystic fibrosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 1, 2016 Category: Pharmaceuticals Source Type: news

Why are drug prices for rare diseases so high? UBC journalism project aims to find out
Why does a family with two children with cystic fibrosis pay up to $1,600 a day for pharmaceuticals? A joint project between UBC's graduate school of journalism and the school’s pharmaceutical sciences department is trying to find out. (Source: CBC | Health)
Source: CBC | Health - February 29, 2016 Category: Consumer Health News Tags: News/Canada/British Columbia Source Type: news

Dozens of celebrities filmed BREATHING for charity video for cystic fibrosis 
The video focuses on cystic fibrosis sufferer Sophie Grace Holmes, 24 She was diagnosed with the disease at four months old. The track is called 'Breathe - Life Unlimited' and features 200 breaths. (Source: the Mail online | Health)
Source: the Mail online | Health - February 29, 2016 Category: Consumer Health News Source Type: news

The Inner Chaos of Anxiety
There's a bottomless well of churning thought and emotion that engulfs the very core of our being and is born of a silent inner strength. That strength unassumingly the very foundation of who we are and the life that courses through every breath. It is the beautiful dance that lives within the purest of inner joys, yet is the weight in which embraces our tears and makes them forcefully fall. It's always present -- alive in our most vulnerable of moments and within a deep tenacious hope. A Piercing Presence But there's a deep anxiety that dares to challenge that strength in which is woven through every honest part of who I ...
Source: Healthy Living - The Huffington Post - February 22, 2016 Category: Consumer Health News Source Type: news

Steven Douglas Associates to Sponsor Inaugural What's Your Taste...
Steven Douglas Associates is a sponsor of the inaugural What’s Your Taste event benefiting Cystic Fibrosis Foundation. The event will be held on Saturday, February 20th 2016 from 6:30 p.m. – 11:00...(PRWeb February 09, 2016)Read the full story at http://www.prweb.com/releases/2016/02/prweb13202923.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 10, 2016 Category: Pharmaceuticals Source Type: news

How cystic fibrosis promotes lung infections
Scientists discovered how cystic fibrosis raises the risk for lung infections. The findings also identify a novel potential therapeutic target. (Source: NIH Research Matters)
Source: NIH Research Matters - February 9, 2016 Category: Research Source Type: news

FDA rejects Vertex's sNDA for Kalydeco to treat cystic fibrosis in people aged two years and older
The US Food and Drug Administration (FDA) has rejected Vertex Pharmaceuticals' supplemental new drug application (sNDA) for Kalydeco (ivacaftor) designed to treat people with cystic fibrosis (CF) aged two and older, with one of 23 residual function m… (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - February 8, 2016 Category: Pharmaceuticals Source Type: news

FDA rejects expanded use of Vertex's cystic fibrosis drug
(Reuters) - The U.S. Food and Drug Administration has denied the expanded use of Vertex Pharmaceutical Inc's bestseller, Kalydeco, in certain cystic fibrosis patients, the company said on Friday. (Source: Reuters: Health)
Source: Reuters: Health - February 5, 2016 Category: Consumer Health News Tags: healthNews Source Type: news

FDA rejects expanded use of Vertex cystic fibrosis drug
(Reuters) - The U.S. Food and Drug Administration has denied the expanded use of Vertex Pharmaceutical Inc's bestseller, Kalydeco, in certain cystic fibrosis patients, the company said on Friday. (Source: Reuters: Health)
Source: Reuters: Health - February 5, 2016 Category: Consumer Health News Tags: healthNews Source Type: news

Fast, accurate cystic fibrosis test developed
Researchers have developed a fast, inexpensive and highly accurate test to screen newborns for cystic fibrosis. The new method detects virtually all mutations in the CF gene, preventing missed diagnoses that delay babies’ ability to begin receiving essential treatment. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 4, 2016 Category: Science Source Type: news

IUPUI chemist receives $1.1 million for research, training of future minority researchers
(Indiana University-Purdue University Indianapolis School of Science) Supported by an NSF CAREER award, Lisa M. Jones of IUPUI is developing a novel approach to study of cell membrane proteins in their native cellular environment -- work fundamental to gaining a better understanding of protein misfolding, which has been linked to life-limiting human diseases including cystic fibrosis. Her work provides state-of-the-art research training for undergraduate students from historically black colleges and universities as well as both undergraduate and graduate students from IUPUI. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - February 3, 2016 Category: Biology Source Type: news

New screening method detects all cystic fibrosis mutations
Stephen FellerSTANFORD, Calif., Feb. 2 (UPI) -- A new method of screening newborns for cystic fibrosis will allow doctors to start treatment as early as possible, Stanford University scientists report. (Source: Health News - UPI.com)
Source: Health News - UPI.com - February 2, 2016 Category: Consumer Health News Source Type: news

UK regulators give go-ahead for 'embryo editing'
"UK scientists have been given the go-ahead by the fertility regulator to genetically modify human embryos," BBC News reports. The UK body that regulates research into embryos – the Human Fertilisation and Embryology Authority (HFEA) – has given a licence to Dr Kathy Niakan for her research on stem cells at The Francis Crick Institute in London.The licence provides permission for genome editing techniques to be used on donated embryos for up to 14 days. The UK is the first country in the world to make this type of research legal. It remains illegal to implant modified embryos ...
Source: NHS News Feed - February 2, 2016 Category: Consumer Health News Tags: Genetics/stem cells QA articles Pregnancy/child Source Type: news

Proteostasis Therapeutics Receives FDA Fast Track Designation for PTI-428 in Patients With Cystic Fibrosis
CAMBRIDGE, MA--(Healthcare Sales & Marketing Network) - Proteostasis Therapeutics, Inc., a company developing novel therapeutics that regulate protein homeostasis to improve outcomes for patients with orphan and protein processing diseases, today announced... Biopharmaceuticals, FDAProteostasis, DRT platform, Cystic Fibrosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 1, 2016 Category: Pharmaceuticals Source Type: news

Role of the clinical pharmacist in the management of CF
This article highlights the essential and varied role of clinical pharmacists as part of the cystic fibrosis (CF) multidisciplinary team (Source: Pharmacy Europe)
Source: Pharmacy Europe - January 29, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: Featured Articles Source Type: news

[Report] Airway acidification initiates host defense abnormalities in cystic fibrosis mice
Cystic fibrosis (CF) is caused by mutations in the gene that encodes the cystic fibrosis transmembrane conductance regulator (CFTR) anion channel. In humans and pigs, the loss of CFTR impairs respiratory host defenses, causing airway infection. But CF mice are spared. We found that in all three species, CFTR secreted bicarbonate into airway surface liquid. In humans and pigs lacking CFTR, unchecked H+ secretion by the nongastric H+/K+ adenosine triphosphatase (ATP12A) acidified airway surface liquid, which impaired airway host defenses. In contrast, mouse airways expressed little ATP12A and secreted minimal H+; consequentl...
Source: ScienceNOW - January 29, 2016 Category: Science Authors: Viral S. Shah Source Type: news

[This Week in Science] Airway infections put to an acid test
Author: Paula A. Kiberstis (Source: ScienceNOW)
Source: ScienceNOW - January 29, 2016 Category: Science Authors: Paula A. Kiberstis Tags: Cystic Fibrosis Source Type: news

Case Western faculty receive funding for new technologies aimed at blood, lung disorders
(Case Western Reserve University) Three Case Western Reserve University faculty members have received funding to further develop emerging technologies aimed at malaria, cystic fibrosis, and sickle cell anemia. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 28, 2016 Category: Infectious Diseases Source Type: news

Inaugural Munck-Pfefferkorn Grants Bring Research Closer to the Marketplace and Helping Patients
The Geisel School of Medicine has announced the inaugural recipients of the annual Munck-Pfefferkorn Awards. Named in honor of two luminaries from the medical school, the endowed award funds new biomedical research projects at Geisel that have high potential to benefit patients and to generate future revenue through grants or entrepreneurial endeavors. (Source: News at Dartmouth Medical School)
Source: News at Dartmouth Medical School - January 26, 2016 Category: Hospital Management Authors: Jennifer Durgin Tags: News Allan Munck biomedical research cancer COPD cystic fibrosis Elmer Pfefferkorn faculty Features grants philanthropy Source Type: news

Cystic Fibrosis Drug Seems OK for Preschoolers: Study
Title: Cystic Fibrosis Drug Seems OK for Preschoolers: StudyCategory: Health NewsCreated: 1/25/2016 12:00:00 AMLast Editorial Review: 1/26/2016 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - January 26, 2016 Category: Respiratory Medicine Source Type: news

Cystic Fibrosis Drug Seems OK for Preschoolers
Finds treatment works and is well-tolerated in 2- to 5-year-olds (Source: WebMD Health)
Source: WebMD Health - January 25, 2016 Category: Consumer Health News Source Type: news

Cystic Fibrosis Drug Seems OK for Preschoolers: Study
Finds treatment works and is well-tolerated in 2- to 5-year-olds (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - January 25, 2016 Category: Respiratory Medicine Authors: webmaster at doctorslounge.com Tags: Pediatrics, Pharmacy, Pulmonology, Research, News, Source Type: news

Anonymous Gifts Totaling $15 million Fuel Cystic Fibrosis Research at Geisel
A $10 million gift from an anonymous donor combined with a $5 million matching gift, also anonymous, will accelerate research aimed at finding better treatments and ultimately a cure for cystic fibrosis at the Geisel School of Medicine at Dartmouth. (Source: News at Dartmouth Medical School)
Source: News at Dartmouth Medical School - January 22, 2016 Category: Hospital Management Authors: Jennifer Durgin Tags: News academic cluster Bruce Stanton cystic fibrosis donor Features gift philanthropy research Source Type: news

Motivations for Personalized Genetic Testing Include Explaining -- Not Just Predicting
Last week, I invited the venerable Lee Hood to speak to us at Harvard Medical School, and I was reminded again of his prescience in describing and advocating for "P4 Medicine" -- or predictive, preventive, personalized and participatory medicine -- over 10 years ago, in 2004! And while Lee's vision of P4 Medicine embraces a model of systems biology that is broader than just the genome, the democratization of genetic testing over the past decade falls squarely within the powerful narrative prediction and prevention. Indeed, much of the controversy surrounding direct-to-consumer (DTC) genetic testing when it launch...
Source: Science - The Huffington Post - January 20, 2016 Category: Science Source Type: news

Nivalis cystic fibrosis drug gets key FDA 'orphan' designation
Nivalis Therapeutics Inc. said the U.S. Food and Drug Administration has given its N91115 cystic fibrosis drug an "orphan drug" designation, and the company's shares soared in Friday trading. Boulder-based Nivalis (Nasdaq: NVLS) shares rose more than 15 percent, rising 77 cents to close at $5.75 on Friday after the FDA announcement. An "orphan drug" designation is given to drugs for diseases that affect less than 200,000 people in the U.S., and gives a drug company a seven-year marketing exclusivity… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 18, 2016 Category: Biotechnology Authors: Ben Miller Source Type: news

NIH genome sequencing program targets the genomic bases of common, rare disease
The National Institutes of Health will fund a set of genome sequencing and analysis centers whose research will focus on understanding the genomic bases of common and rare human diseases. The National Human Genome Research Institute (NHGRI), part of NIH, today launched the Centers for Common Disease Genomics (CCDG), which will use genome sequencing to explore the genomic contributions to common diseases such as heart disease, diabetes, stroke and autism. NHGRI also announced the next phase of a complementary program, the Centers for Mendelian Genomics (CMG), which will continue investigating the genomic underpinnings of ra...
Source: NHGRI Press Releases - January 14, 2016 Category: Genetics & Stem Cells Source Type: news

Researchers further illuminate pathway for treatment of cystic fibrosis
New research findings add further clarity to a question that has polarized the cystic fibrosis (CF) research community. It is well established that people with cystic fibrosis have two faulty copies of the CFTR gene, but debate continues on the question of whether certain symptoms of the airway disease are caused by the mutation or if the genetic defect precedes, but does not directly lead to some of the worst symptoms patients face. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 12, 2016 Category: Science Source Type: news

Manchester teen with cystic fibrosis writes bucket list before she dies
Chloe Hopkins, 19 of Manchester, has cystic fibrosis and her health is deteriorating. Without a double lung transplant, doctors have said she won't live more than two years (Source: the Mail online | Health)
Source: the Mail online | Health - January 12, 2016 Category: Consumer Health News Source Type: news

Advanced Inhalation Therapies scales back IPO terms to $10m
Advanced Inhalation Therapies yesterday scaled its pending initial public offering by more than ⅔ as it looks to raise funds for its drug delivery device, which is designed to treat severe respiratory infections and lung diseases using a high dose of nitric oxide. When it registered for the IPO back in August 2015, Rehovot, Israel-based AIT set the high end of the offering at $36 million. Yesterday the company said it plans to float 675,000 shares at $15 apiece, for gross proceeds of $10.1 million. Losses for AIT last year widened by 200%, to -$4.6 million, or -41¢ per share, compared with&n...
Source: Mass Device - January 12, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Funding Roundup Initial Public Offering (IPO) Respiratory Advanced Inhalation Therapies Source Type: news

What Are Risk Factors for Cholelithiasis?
Discussion Bile is produced by the liver to aid absorption of fat soluble vitamins and lipids from the gastrointestinal tract and to transport bilirubin, cholesterol and other substances to the gastrointestinal tract. Bile is the main form of cholesterol excretion. Gallstones or cholelithiasis form when the balance of substances within the hepatobiliary tract favors supersaturation with crystal formation and gallstone formation. It is a dynamic state of affairs as gallstones can form and also have a high rate of resorption of up to 50%. Gallstones 3 mm are called gallstones. Gallstones, while not as common as adult popula...
Source: PediatricEducation.org - January 4, 2016 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Mapping a way to medication adherence
Eighteen-year-old Maggie Mansfield, a communications major at Boston College, is a two-time double-lung transplant recipient — once, at age 4, due to a condition called pulmonary hypertension in which blood pressure in the arteries of the lungs is abnormally high, and again at age 7, when her body rejected the first transplant. Since then, Maggie has remained relatively healthy due in part to her strict medication regimen. Maggie Mansfield “Timing is the most challenging part of taking my medications,” Maggie says. “As I get older, I get busier. It’s not always easy to stop what I am doing and...
Source: Thrive, Children's Hospital Boston - December 29, 2015 Category: Pediatrics Authors: Emily Williams Tags: Health & Wellness Our Patients’ Stories Teen Health double lung transplant Liver transplant Pediatric Transplant Center (PTC) prescription medication pulmonary hypertension Source Type: news

Behind the Headlines' Top Five of Top Fives 2015
In this study, researchers wanted to see why this is and if there could be any human applications.Researchers collected white blood cells from African and Asian elephants. They found that elephants have at least 20 copies of a gene called TP53. TP53 is known to encourage cell "suicide" when DNA is damaged, stopping any potential cancer in its tracks. In contrast, humans are thought to have only a single copy of the TP53 gene.Of course the big question – the elephant in the room, if you will – is how we can boost TP53 activity in humans to stimulate a similar protective effect. The simple answer is: we...
Source: NHS News Feed - December 24, 2015 Category: Consumer Health News Tags: QA articles Medical practice Special reports Source Type: news

Behind the Headlines Top Five of Top Fives 2015
In this study, researchers wanted to see why this is and if there could be any human applications. Researchers collected white blood cells from African and Asian elephants. They found elephants have at least 20 copies of a gene called TP53. TP53 is known to encourage cell "suicide" when DNA is damaged, stopping any potential cancer in its tracks. In contrast, humans are thought to have only a single copy of the TP53 gene. Of course the big question – the elephant in the room, if you will – is how we can boost TP53 activity in humans to stimulate a similar protective effect. The simple answer is: we do...
Source: NHS News Feed - December 24, 2015 Category: Consumer Health News Tags: QA articles Medical practice Special reports Source Type: news

News Quiz: 2015 an Important Year for the LungsNews Quiz: 2015 an Important Year for the Lungs
New drugs for COPD, asthma, and cystic fibrosis made headlines this year. Experts debated the apnea treatment vacuum and what to do about tricky pulmonary fibrosis and contaminated bronchoscopes. Test how well you kept up with the news this year Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 22, 2015 Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news

Case Western Reserve School of Nursing scientist to lead new cystic fibrosis research
(Case Western Reserve University) A scientist at Case Western Reserve University Frances Payne Bolton School of Nursing will lead a pair of studies to develop more effective treatment for symptoms of cystic fibrosis (CF), a life-threatening genetic disease that causes persistent lung infections and progressively limits the ability to breathe. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - December 17, 2015 Category: Biology Source Type: news